YiChang HEC ChangJiang Pharmaceutical Co., Ltd. (HKG: 1558)
Hong Kong
· Delayed Price · Currency is HKD 9.39
+0.04 (0.43%)
Nov 14, 2024, 4:08 PM HKT
YiChang HEC ChangJiang Pharmaceutical Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Cash & Equivalents | 1,523 | 1,674 | 923.54 | 1,131 | 2,045 | 2,779 | Upgrade
|
| Trading Asset Securities | - | 18.69 | 290 | - | - | - | Upgrade
|
| Cash & Short-Term Investments | 1,523 | 1,693 | 1,214 | 1,131 | 2,045 | 2,779 | Upgrade
|
| Cash Growth | -59.72% | 39.52% | 7.29% | -44.69% | -26.42% | 368.07% | Upgrade
|
| Accounts Receivable | 1,850 | 2,073 | 1,006 | 479.04 | 460.51 | 2,196 | Upgrade
|
| Other Receivables | 38.77 | 40.19 | 31.1 | 67.75 | 139.25 | 148.57 | Upgrade
|
| Receivables | 1,889 | 2,113 | 1,037 | 546.79 | 599.76 | 2,345 | Upgrade
|
| Inventory | 581.15 | 409.05 | 315.03 | 279.7 | 378.27 | 206.62 | Upgrade
|
| Restricted Cash | 973.43 | 1,567 | 76.78 | 91.99 | 221.19 | - | Upgrade
|
| Other Current Assets | 404.91 | 270.81 | 2,372 | 7.78 | 19.93 | - | Upgrade
|
| Total Current Assets | 5,469 | 6,053 | 5,014 | 2,057 | 3,264 | 5,331 | Upgrade
|
| Property, Plant & Equipment | 3,910 | 3,740 | 3,519 | 3,217 | 2,836 | 2,026 | Upgrade
|
| Long-Term Investments | 25.62 | 32.16 | - | 1,790 | - | - | Upgrade
|
| Goodwill | - | - | - | 75.9 | 75.9 | 75.9 | Upgrade
|
| Other Intangible Assets | 1,374 | 1,470 | 1,782 | 2,071 | 1,536 | 534.05 | Upgrade
|
| Long-Term Deferred Tax Assets | 204.59 | 237.69 | 140.61 | 65.32 | 40.65 | 95.76 | Upgrade
|
| Long-Term Deferred Charges | 1,188 | 1,095 | 1,138 | 1,201 | 1,173 | 294.25 | Upgrade
|
| Other Long-Term Assets | 323.21 | 115.38 | 295.76 | 64.83 | 635.32 | 1,556 | Upgrade
|
| Total Assets | 12,494 | 12,744 | 11,890 | 10,542 | 9,561 | 9,912 | Upgrade
|
| Accounts Payable | 467.57 | 200.52 | 178.61 | 193.47 | 244.94 | 184.7 | Upgrade
|
| Accrued Expenses | 617.78 | 1,397 | 1,342 | 480.34 | 786.68 | 1,519 | Upgrade
|
| Short-Term Debt | - | - | - | - | 345.99 | 132.66 | Upgrade
|
| Current Portion of Long-Term Debt | 1,077 | 2,165 | 3,055 | 48.48 | 2,475 | - | Upgrade
|
| Current Portion of Leases | 156.14 | 154.44 | 75.44 | - | - | - | Upgrade
|
| Current Income Taxes Payable | 1.28 | 146.21 | 8.67 | 198.63 | 20.44 | 155.06 | Upgrade
|
| Current Unearned Revenue | 57.44 | 109.64 | 83.58 | 79.28 | 60.53 | 135.71 | Upgrade
|
| Other Current Liabilities | 160.91 | 158.48 | 197.86 | 237.87 | 227.82 | 184.99 | Upgrade
|
| Total Current Liabilities | 2,538 | 4,332 | 4,941 | 1,238 | 4,161 | 2,312 | Upgrade
|
| Long-Term Debt | 990.78 | 254 | 629.03 | 3,145 | 189.85 | 2,903 | Upgrade
|
| Long-Term Leases | 115.03 | 35.45 | 62.5 | - | - | - | Upgrade
|
| Long-Term Unearned Revenue | 184.55 | 187.15 | 187.49 | 137.73 | 106.54 | 74.94 | Upgrade
|
| Total Liabilities | 3,829 | 4,809 | 5,820 | 4,521 | 4,458 | 5,289 | Upgrade
|
| Common Stock | 879.97 | 879.97 | 879.97 | 879.97 | 879.97 | 448.82 | Upgrade
|
| Retained Earnings | 5,072 | 4,387 | 2,395 | 2,318 | 2,906 | 2,726 | Upgrade
|
| Treasury Stock | - | - | - | - | - | -142.21 | Upgrade
|
| Comprehensive Income & Other | 2,714 | 2,668 | 2,610 | 2,610 | 1,106 | 1,376 | Upgrade
|
| Total Common Equity | 8,665 | 7,936 | 5,885 | 5,808 | 4,891 | 4,409 | Upgrade
|
| Minority Interest | - | - | 185.12 | 212.48 | 212.56 | 214.6 | Upgrade
|
| Shareholders' Equity | 8,665 | 7,936 | 6,070 | 6,021 | 5,104 | 4,623 | Upgrade
|
| Total Liabilities & Equity | 12,494 | 12,744 | 11,890 | 10,542 | 9,561 | 9,912 | Upgrade
|
| Total Debt | 2,339 | 2,609 | 3,822 | 3,194 | 3,011 | 3,035 | Upgrade
|
| Net Cash (Debt) | -816.17 | -916.23 | -2,608 | -2,062 | -965.69 | -256.12 | Upgrade
|
| Net Cash Per Share | -0.93 | -1.04 | -2.96 | -2.34 | -0.87 | -0.25 | Upgrade
|
| Filing Date Shares Outstanding | 879.97 | 879.97 | 879.97 | 879.97 | 879.97 | 889.79 | Upgrade
|
| Total Common Shares Outstanding | 879.97 | 879.97 | 879.97 | 879.97 | 879.97 | 889.79 | Upgrade
|
| Working Capital | 2,930 | 1,721 | 73.24 | 819.31 | -897.1 | 3,019 | Upgrade
|
| Book Value Per Share | 9.85 | 9.02 | 6.69 | 6.60 | 5.56 | 4.95 | Upgrade
|
| Tangible Book Value | 7,292 | 6,465 | 4,103 | 3,662 | 3,279 | 3,799 | Upgrade
|
| Tangible Book Value Per Share | 8.29 | 7.35 | 4.66 | 4.16 | 3.73 | 4.27 | Upgrade
|
| Machinery | 3,539 | 3,448 | 3,021 | 2,680 | 1,601 | 1,357 | Upgrade
|
| Construction In Progress | 801.52 | 638.2 | 675.45 | 567.94 | 1,187 | 678.33 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.